http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2742196-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7d33206fac8cc463c5908fa9fbbbc576
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82B1-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B82B1-00
filingDate 2019-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d147baae00c3d399f3a953bfaf44e0b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9dfe678c0f2bb46c1b8f4e448d7971f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72857e62da020e398958c10bf0ef152a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88887c582dca543fcda652abb42c04b5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49ecfa1d25be6239e56844fc7ee29c7b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8be8f9b33b15e66e0b8daed91baae8a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2938269e459108c70fa83e626aeb696
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71343ca42d0e6e81305c80f0a03ebec6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e5b2aaf83daa9aac33397b2c27b56e2
publicationDate 2021-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2742196-C1
titleOfInvention Pharmaceutical composition for preparing injection solution when used in treating magnetic hyperthermia and method for preparing thereof
abstract FIELD: medicine.SUBSTANCE: invention can be used for preparing a solution for injections used in treating oncological diseases by magnetic hyperthermia and a method for preparing it. Essence of the invention is that the pharmaceutical composition for preparing the injection solution when used in treating magnetic hyperthermia is a lyophilisate of a solution of magnetic nanoparticles of cobalt ferrite (CoFe2O4) with size of not more than 20 nm, coated with sorbitol molecules, with following ratio of components, wt. %: cobalt ferrite 70–75, sorbitol 25–30.EFFECT: technical result: enabling re-dissolution of the declared pharmaceutical composition and repeated drying with preservation of its stability and pharmacological properties, longer storage life of the solution prepared from the declared pharmaceutical composition.8 cl, 6 tbl, 37 dwg
priorityDate 2019-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2563211-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2633918-C9
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006125452-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009142439-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409060395
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82170
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14789
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527028
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453265332
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3032536
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452862991
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID311
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62687
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451005226
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID944
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474445
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5780
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24643
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449025518
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16211566
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490943
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24380
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24527
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419525871
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452260893
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104730
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14798
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6001
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559357
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416645804
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419585166
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458391437

Total number of triples: 58.